This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Infiltrating Lobular Carcinoma

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Infiltrating Lobular Carcinoma Means

Infiltrating Lobular Carcinoma, also called Invasive Lobular Carcinoma, is a type of breast cancer that begins in the lobules, which are the milk-producing glands in the breast. Unlike cancers that start in the milk ducts, this cancer grows beyond the lobules and spreads into the nearby normal breast tissue. Because it has invaded surrounding tissue, it is considered invasive or infiltrating. This cancer can also travel through the blood and lymph systems to other parts of the body.

Why It Can Matter in Cancer Care

This type of breast cancer is important to identify because its behavior and treatment may differ from other breast cancers. Since it can spread beyond the breast, early detection and careful diagnosis are key to planning the best treatment. Knowing that the cancer started in the lobules helps doctors understand its characteristics and potential growth patterns. Treatment decisions often depend on how far the cancer has spread, its size, and other features specific to each person.

What Patients Might See or Hear

Patients may encounter the term Infiltrating Lobular Carcinoma in medical reports, biopsy results, or when discussing diagnosis and treatment options with their healthcare providers. Sometimes the term Invasive Lobular Carcinoma is used instead, but both mean the same condition. Because medical language can be confusing, it’s important to ask your care team to explain what this diagnosis means for your specific case, including what tests were done and what treatment options are recommended.

Common Confusions and Related Terms

Infiltrating Lobular Carcinoma is different from lobular carcinoma in situ (LCIS), which is a non-invasive condition where abnormal cells are found in the lobules but have not spread. LCIS is considered a risk factor for developing invasive cancer but is not cancer itself. The terms invasive and infiltrating lobular carcinoma are used interchangeably. It’s also helpful to know that infiltrating breast cancer can start in ducts or lobules, with infiltrating ductal carcinoma being the most common type. Understanding these differences can help avoid confusion when reading medical information.

How to Read the Term in Context

Seeing the term Infiltrating Lobular Carcinoma in a report does not by itself determine treatment or prognosis. It is one part of a larger picture that includes the cancer’s size, grade, whether it has spread to lymph nodes or other areas, and other test results. Always discuss with your healthcare team how this diagnosis applies to your individual situation. They can explain what the term means in your report and how it influences your care plan.

Safety and Next Steps

This information is meant to help you understand the term and does not replace medical advice. Every person’s cancer is unique, and treatment decisions depend on many factors beyond the name of the cancer. If you see this term in your medical records or hear it during your care, the best next step is to ask your healthcare providers to explain what it means for you personally. Understanding your diagnosis helps you feel more informed and involved in your care.

Sources

Public source information used for this glossary entry includes: